Home
Search
Placeholder Banner
Letters, Testimony and Comments

CSBA Letter to Congressional Leadership on Reauthorization of the Rare Pediatric Disease Priority Review Voucher Program

September 9, 2024
Download Full Comments Below
CSBA Letter to Congressional Leadership on Reauthorization of the Rare Pediatric Disease Priority Review Voucher Program
Download
Discover More
CSBA letter to USITC Expressing Concerns with…
Learn more
CSBA Letter in Support of ORPHAN Cures Act
The Council of State Bioscience Associations wrote House and Senate leaders to urge support of H.R. 5539 and S. 3131, the Optimizing Research Progress Hope and New Cures Act. 
Learn more
CSBA Letter to Congressional Leadership Urging…
This bipartisan and bicameral legislation is aimed at boosting rare disease drug development to ensure that patients have access to innovative therapies.
Learn more